Zacks Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,692	Closed	-$20.6K	–	741
2025 Q1	$20.6K	Buy	+45,692	New	+$20.6K	﹤0.01%	649
2019 Q3	–	Sell	-77,609	Closed	-$85K	–	552
2019 Q2	$85K	Buy	+77,609	New	+$85K	﹤0.01%	518